Plasma Dihydroceramides Are Diabetes Susceptibility Biomarker Candidates in Mice and Humans

Authors:

Abstract
No abstract available
Funding Information
  • Seventh Framework Programme
  • Innovative Medicines Initiative (155005)
  • Swiss Institute of Bioinformatics
  • GlaxoSmithKline
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (3100A0B-128657, 33CS30-139468, 33CS30-148401, 33CSCO-122661)
  • Boehringer Ingelheim

This publication has 34 references indexed in Scilit: